Old Web
English
Sign In
Acemap
>
authorDetail
>
Wendell Wierenga
Wendell Wierenga
Johns Hopkins University
Pharmacology
Medicine
Potency
Pharmacokinetics
Immunology
3
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AC220, a Potent and Specific FLT3 Inhibitor, Enhances the Activity of Combined Cytarabine and Daunorubicin Chemotherapy in a FLT3-ITD Model of AML
2011
Blood
Barbara Belli
Alan Dao
Wendell Wierenga
Robert C. Armstrong
Show All
Source
Cite
Save
Citations (2)
Clinical Pharmacokinetics and FLT3 Phosphorylation of AC220, a Highly Potent and Selective Inhibitor of FLT3
2008
Blood
Joyce James
Keith W. Pratz
Adam Stine
Julius L. Apuy
Darren E Insko
Robert C Armstrong
Patrick P Zarrinkar
Donald Small
Wendell Wierenga
Mark J. Levis
Show All
Source
Cite
Save
Citations (13)
Human Pharmacokinetics of AC220, a Potent and Selective Class III Receptor Tyrosine Kinase Inhibitor.
2007
Blood
Jorge E. Cortes
James M. Foran
Marcel P. Devetten
Francis J. Giles
Joyce James
Patrick P. Zarrinkar
Michael H Silverman
Kerry A. Kelly
Norman M. Padre
Shripad S. Bhagwat
Wendell Wierenga
Show All
Source
Cite
Save
Citations (8)
1